
The companies focus on fibrosis and oncology, and novel treatments for respiratory conditions, respectively

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

The companies plan to research and develop 12 new cancer treatments

The treatment is currently being evaluated in a phase 1/2 multicentre clinical study

The acquisition builds on Gilead’s oncology pipeline, focused on addressing areas of high unmet need

See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.